The daily burden for those living with type 1 diabetes is constant, and Breakthrough T1D remains focused on accelerating the path to cures for the disease,” said Nicholas Mamrak, Ph.D., scientist at ...

Cell therapies are already here, with treatments now available for some cancers and rare diseases. But bringing such living medicines to more patients presents both scientific and financial challenges ...

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a preclinical-stage biotechnology company, has launched with backing from Astellas Venture Management LLC and Illumina Ventures. Other investors include DCVCBio, ...

Spectral Labs, a crypto development firm focused on artificial intelligence, wants to make it easier for non-programmers to build on blockchains. On Tuesday the company will launch Syntax, an AI app ...

Human language is based on syntax, a complex set of rules about how words can be combined. In theory, the emergence of syntactic communication might have been a comparatively straightforward process.